Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Biomet Reports Drop in First-Quarter Earnings - Orthopedic Design & Technology

Biomet Reports Drop in First-Quarter Earnings

But company posts higher sales in nearly all divisions.

Net income at Biomet Inc. plummeted 77 percent year-over-year to $7.3 million as higher expenses offest revenue increases in nearly all divisions. Overall sales rose 6 percent to $774.8 million, led by gains in the company’s spine, bone healing and microfixation segment.

The Warsaw, Ind.-based manufacturer of artificial knees and hips, among other orthopedic devices, agreed in April to be acquired by rival Zimmer Holdings Inc. for about $13.35 billion in cash and stock, a bid to position the combined company as a leader in muscle and bone repair products. That move effectively ended Biomet’s plan for an initial public offering earlier this year.

Several weeks ago, European Union directors opened an in-depth probe into the deal, saying it could result in less innovation and higher prices. The decision raises a potential hurdle to the landmark deal, which has yet to be approved by U.S. regulators.

For the quarter ended Aug. 31, Biomet posted a profit of $7.3 million, down from a profit of $31.1 million a year earlier. Excluding items, adjusted net income rose to $94.6 million from $77.1 million a year earlier. Sales rose 6 percent, led by a 21 percent sales increase in its spine and bone healing division.

Revenue from Biomet’s knee division rose 4.3 percent to $234.7 million and hip division proceeds increased 3.8 percent to$155.3 million, according to the latest earnings statement. Sales from the company’s sports, extremities and trauma segment were up 3.4 percent year-over-year to $154.5 million, while revenue from spine, bone healing and microfixation products jumped 21 percent to $122.8 million.

Reported operating income fell 14.4 percent to $82.5 million; however, excluding special items, adjusted operating income rose 4.5 percent to $197.1 million.

Meanwhile, research and development costs rose 14 percent in the quarter, while selling and administrative expenses rose 15 percent.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters